delete The Patents (Isle of Man) (Amendment) (EU Exit) Order 2019
Brexit-related statutory instrument amending the Patents (Isle of Man) Order 2013 to extend EU Withdrawal Act 2018 regulatory amendments to the Isle of Man, rename 'EU compulsory licences' to 'compulsory pharmaceutical licences', and preserve the definition of the Council Regulation as it stood before exit day.
This Order perpetuates EU-derived regulation in the Isle of Man under the guise of Brexit continuity. Rather than seizing post-Brexit regulatory freedom, it merely transplants EU-era rules to a separate jurisdiction. The renaming of 'EU compulsory licences' to 'compulsory pharmaceutical licences' is cosmetic rather than substantive reform. Deleting this would signal intent to treat the Isle of Man as a genuinely independent jurisdiction capable of setting its own patent framework, potentially attracting life sciences investment by offering more flexible IP protections than either the UK or EU.